HIKAL
Hikal Share Price
Hikal Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in HIKAL
Start SIPHikal Investment Rating
-
Master Rating:
-
Hikal has an operating revenue of Rs. 1,954.42 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 15% is good. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 2% and 1% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 129 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 557 | 371 | 501 | 515 | 469 | 455 | 532 |
| Operating Expenses Qtr Cr | 489 | 356 | 441 | 422 | 378 | 361 | 423 |
| Operating Profit Qtr Cr | 70 | 23 | 61 | 93 | 91 | 96 | 109 |
| Depreciation Qtr Cr | 27 | 27 | 24 | 25 | 24 | 23 | 22 |
| Interest Qtr Cr | 11 | 11 | 8 | 7 | 8 | 8 | 10 |
| Tax Qtr Cr | 8 | -3 | 8 | 16 | 16 | 18 | 30 |
| Net Profit Qtr Cr | 25 | -9 | 21 | 45 | 44 | 51 | 51 |
Hikal Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- 335.9
- 50 Day
- 331.59
- 100 Day
- 330.44
- 200 Day
- 339.06
- 20 Day
- 336.66
- 50 Day
- 336.53
- 100 Day
- 310.27
- 200 Day
- 338.65
Hikal Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 340.7 |
| Second Resistance | 345.8 |
| Third Resistance | 348.65 |
| RSI | 57.37 |
| MFI | 68.41 |
| MACD Single Line | 0.84 |
| MACD | 1.26 |
| Support | |
|---|---|
| First Resistance | 332.75 |
| Second Resistance | 329.9 |
| Third Resistance | 324.8 |
Hikal Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 232,142 | 9,494,608 | 40.9 |
| Week | 135,208 | 6,365,611 | 47.08 |
| 1 Month | 213,807 | 8,353,445 | 39.07 |
| 6 Month | 633,530 | 22,293,910 | 35.19 |
Hikal Result Highlights
Hikal Synopsis
NSE-Medical-Diversified
Hikal Ltd. is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1720.44 Cr. and Equity Capital is Rs. 24.66 Cr. for the Year ended 31/03/2021. Hikal Ltd. is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028.| Market Cap | 4,253 |
| Sales | 1,954 |
| Shares in Float | 3.82 |
| No of funds | 64 |
| Yield | 0.46 |
| Book Value | 3.98 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | 27 |
| Alpha | -0.15 |
| Beta | 1.18 |
Hikal
| Owner Name | Sep-22 | Jun-22 | Mar-22 | Dec-21 |
|---|---|---|---|---|
| Promoters | 68.77% | 68.77% | 68.77% | |
| Mutual Funds | 1.1% | 0.77% | 0.76% | |
| Insurance Companies | 0.12% | 0.12% | 0.12% | |
| Foreign Portfolio Investors | 4.27% | 3.91% | 6.92% | |
| Individual Investors | 19.2% | 18.54% | 18.06% | |
| Others | 6.54% | 7.89% | 5.37% |
Hikal Management
| Name | Designation |
|---|---|
| Mr. Jai Hiremath | Executive Chairman |
| Mr. Sameer Hiremath | Managing Director |
| Ms. Sugandha Hiremath | Director |
| Mrs. Shivani Bhasin Sachdeva | Director |
| Mr. Ranjit Shahani | Director |
| Mr. Kannan Unni | Director |
| Mr. Amit Kalyani | Director |
| Mr. Baba Kalyani | Director |
| Mr. Prakash Mehta | Director |
| Mr. Shrikrishna Adivarekar | Director |
Hikal Forecast
Price Estimates
Hikal Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2022-11-09 | Quarterly Results | |
| 2022-08-10 | Quarterly Results | |
| 2022-05-28 | Audited Results & Final Dividend | |
| 2022-02-14 | Quarterly Results & Interim Dividend | |
| 2021-10-26 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-09-15 | FINAL | Rs.0.40 per share(20%)Final Dividend |
| 2022-02-24 | INTERIM | Rs.1.20 per share(60%)Interim Dividend |
| 2021-08-26 | FINAL | Rs.1.00 per share(50%)Final Dividend |
| 2021-02-16 | INTERIM | Rs.1.00 per share(50%)Interim Dividend |
Hikal FAQs
What is Share Price of Hikal ?
Hikal share price is ₹344 As on 26 November, 2022 | 14:22
What is the Market Cap of Hikal ?
The Market Cap of Hikal is ₹4253.3 Cr As on 26 November, 2022 | 14:22
What is the P/E ratio of Hikal ?
The P/E ratio of Hikal is 51.9 As on 26 November, 2022 | 14:22
What is the PB ratio of Hikal ?
The PB ratio of Hikal is 4 As on 26 November, 2022 | 14:22